Nomogram for Predicting Resistance to Sunitinib in Patients with Metastatic Clear Cell Renal Carcinoma

被引：0
|
作者：
Kammerer-Jacquet, S-F
Belaud-Rotureau, M-A
Oger, E.
Verhoest, G.
Lespagnol, A.
Edeline, J.
Jaillard, S.
Laguerre, B.
Vauleon, E.
Mosser, J.
Bensalah, K.
Rioux-Leclercq, N.
机构：
[1] CHU, Rennes, France
[2] CRLCC, Rennes, France
来源：
LABORATORY INVESTIGATION | 2014年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
978
引用
收藏
页码：238A / 238A
页数：1
相关论文
共 50 条
  • [31] Tolerance of Sunitinib in Dialyzed Patients With Metastatic Renal Cell Carcinoma
    Vickers, Michael M.
    Heng, Daniel Y.
    Hemmelgarn, Brenda
    Eigl, Bernhard J.
    CLINICAL GENITOURINARY CANCER, 2009, 7 (03) : E104 - E106
  • [32] Sunitinib in patients with metastatic renal cell carcinoma: Birmingham experience
    Ansari, Jawaher
    Fatima, Arfeen
    Fernando, Kieran
    Collins, Stuart
    James, Nicholas D.
    Porfiri, Emilio
    ONCOLOGY REPORTS, 2010, 24 (02) : 507 - 510
  • [33] Blocking stanniocalcin 2 reduces sunitinib resistance in clear cell renal cell carcinoma
    Qin, Zhen-Qian
    Li, Kong-Dong
    Chu, He-Zhen
    Yuan, Xue-Feng
    Shi, Hai-Feng
    Gu, Jie
    Xie, Yi-Min
    NEOPLASMA, 2022, 69 (01) : 145 - 154
  • [34] Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib
    Rini, Brian I.
    Tamaskar, Ila
    Shaheen, Phillip
    Salas, Renee
    Garcia, Jorge
    Wood, Laura
    Reddy, Sethu
    Dreicer, Robert
    Bukowski, Ronald M.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (01): : 81 - 83
  • [35] Site of metastasis in metastatic clear cell renal cell carcinoma (mccRCC) and outcome of treatment with sunitinib
    Beuselinck, B.
    Rixe, O.
    Oudard, S.
    Wolter, P.
    Ayllon, J.
    Elaidi, R.
    Schoffski, P.
    Scotte, F.
    Zucman-Rossi, J.
    Medioni, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [36] An immune scores-based nomogram for predicting overall survival in patients with clear cell renal cell carcinoma
    Wu, Zhulin
    Ouyang, Chensheng
    Peng, Lisheng
    MEDICINE, 2020, 99 (34) : E21693
  • [37] Immune expression profile and sunitinib benefit in metastatic clear cell renal cell carcinoma (ccRCC)
    Reig Torras, O.
    Marin-Aguilera, M.
    Jimenez, N.
    Pare, L.
    Galvan, P.
    Mallofre, C.
    Prat, A.
    Mellado Gonzalez, B.
    ANNALS OF ONCOLOGY, 2017, 28
  • [38] Sunitinib in Metastatic Renal Cell Carcinoma Patients With Brain Metastases
    Gore, Martin E.
    Hariharan, Subramanian
    Porta, Camillo
    Bracarda, Sergio
    Hawkins, Robert
    Bjarnason, Georg A.
    Oudard, Stephane
    Lee, Se-Hoon
    Carteni, Giacomo
    Nieto, Alejandra
    Yuan, Jinyu
    Szczylik, Cezary
    CANCER, 2011, 117 (03) : 501 - 509
  • [39] Alternate sunitinib schedules in patients with metastatic renal cell carcinoma
    Kalra, S.
    Rini, B. I.
    Jonasch, E.
    ANNALS OF ONCOLOGY, 2015, 26 (07) : 1300 - 1304
  • [40] Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated with Sunitinib Response in the Metastatic Setting
    Beuselinck, Benoit
    Job, Sylvie
    Becht, Etienne
    Karadimou, Alexandra
    Verkarre, Virginie
    Couchy, Gabrielle
    Giraldo, Nicolas
    Rioux-Leclercq, Nathalie
    Molinie, Vincent
    Sibony, Mathilde
    Elaidi, Reza
    Teghom, Corinne
    Patard, Jean-Jacques
    Mejean, Arnaud
    Fridman, Wolf Herman
    Sautes-Fridman, Catherine
    de Reynies, Aurelien
    Oudard, Stephane
    Zucman-Rossi, Jessica
    CLINICAL CANCER RESEARCH, 2015, 21 (06) : 1329 - 1339
12345